As of 2024-12-14, the Fair Value of Chinook Therapeutics Inc (KDNY) is -17.11 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 40.39 USD, the upside of Chinook Therapeutics Inc is -142.35%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -95.36 | -82.37 | -81.62 | -102.94 | -187.87 | -110.03 |
| YoY growth | -3.81% | 13.62% | 0.91% | -26.12% | -82.50% | -19.58% |
| Market Cap (mil) | 2,900.20 |
| P/E | |
| Forward P/E |
| EPS | -3.42 |
| Avg earnings growth rate | -19.58% |
| TTM earnings | -245.65 |